News FocusCell Biology

Still Waiting Their Turn

See allHide authors and affiliations

Science  10 Jun 2005:
Vol. 308, Issue 5728, pp. 1536-1537
DOI: 10.1126/science.308.5728.1536

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Even enthusiasts agree that Geron's goal--to begin testing a human embryonic stem cell therapy in patients with spinal cord injury within a year--is a long shot.